EP 41 - Wash Everything

Today we look at a wonder drug that will redefine what it takes to be beautiful and then we will examine a subculture that believes AIDS is a "gift" to be shared with others. Patreon https://www.patreon.com/user?u=18482113 MERCH STORE!!! https://tinyurl.com/y8zam4o2 "Tren Tanning" is a phrase many have never heard. But it will soon become a common notion. With the steroid Melanotan 2, people can get a healthy tan, lose weight, and increase thier sex drive. The future is only a needle prick away. Then, we investigate the urban legend of "Bugchasing." Is there really a group of men who seek out AIDS-infected partners? Why would anyone want a deadly disease? And even more odd . . .who would do it on camera? Melanotan 2: The Wonder Drug https://www.steroid.com/Melanotan-II.php https://www.webmd.com/vitamins/ai/ingredientmono-884/melanotan-iihttps://en.wikipedia.org/wiki/Bremelanotide A Porn Director Stirred Up Controversy by Making a Movie Centered Around HIV https://www.vice.com/en_us/article/yvqbgm/director-paul-morris-believes-hiv-should-be-part-of-gay-porn I Am A Bugchaser. Ask Me Anything https://www.reddit.com/r/IAmA/comments/ficch/iama_bugchaser_ama/ The Men Who Want AIDS—and How It Improved Their Lives https://www.out.com/news-opinion/2013/08/02/men-who-want-aids-bronx-new-york WARNING: View these posts at your peril http://oi43.tinypic.com/24micci.jpg http://reddittt.com/post/7tk769/ Listen to the daily podcast anywhere you listen to podcasts! ------------------------------------------------ Logo Art By Ash Black Opening Song: "Atlantis Attacks" Closing Song: "Bella Royale" Music By Dr. Huxxxtable Hood River http://www.DeadRabbit.com Email: [email protected] Twitter: @DeadRabbitRadio Facebook: www.Facebook.com/DeadRabbitRadio Paranormal, Conspiracy, and True Crime news as it happens! Jason Carpenter breaks the stories they'll be talking about tomorrow, assuming the world doesn't end today. All Contents Of This Podcast Copyright Jason Carpenter 2018 - 2020

There are no comments yet.

Please log in to write the first comment.